-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Jounce Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2017 to Q4 2022.
- Jounce Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2022 was -30.9 %, a 12.2% increase year-over-year.
- Jounce Therapeutics, Inc. annual Return On Equity for 2022 was -30.9 %, a 12.2% increase from 2021.
- Jounce Therapeutics, Inc. annual Return On Equity for 2021 was -35.2 %, a 19.6% decline from 2020.
- Jounce Therapeutics, Inc. annual Return On Equity for 2020 was -29.4 %, a 171% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)